Back Home

Maximizing Immunoassay Performance

Maximizing Immunoassay Performance

  • HOME
  • ABOUT US
    • Founders
    • Why InfYnity
    • Who we are
    • What we do
  • OFFER
    • Biomaterial Products
    • Biomaterial Design
    • Immunoassay RUO products
    • Immunoassay Development Services
    • Multiplex Services
  • CONTACT US
    • Careers
  • Pipeline
  • Partners
Home » 2018 » October » 22

News

  • Lancet Infectious Disease publication on an innovative multiplex test for forecasting parasitological cure in Chagas patients
  • InfYnity Multiplex ELISA Platform: Reliable & Highly Reproducible
  • MEDICA (November 18-21, 2019)
  • HERVS & Disease (November 5-6, 2019)
  • Chagas Disease Monitoring: Time for analysis of serological patterns
  • NIH Award to develop a Test-of-Cure for Chagas disease
  • Stars of Science – Session 10 (2018)
  • Chagas Platform Meeting (November 14-15, 2018)
  • MEDICA (November 12-15, 2018)
  • Biotuesday (September 4, 2018)

Daily Archives: October 22, 2018


We are excited to be invited at the Chagas Platform Meeting, in Santa Cruz, Bolivia. With our partners at DNDi and in the Chagas community, our CSO, Maan Zrein, will discuss the latest developments in biomarkers research and help to define the roadmap towards a treatment monitoring test.

Chagas Platform Meeting (November 14-15, 2018)

22 Oct, 2018  in Biotechnology by admin


INFYNITY BIOMARKERS

78-80 rue du Bourbonnais
69009 Lyon – France

Tel: +33 4 72 76 20 29
Fax: +33 9 81 38 17 15
Email: info@infynity-biomarkers.com

Map: https://map.what3words.com/portique.retrouvons.sportif

Mentions Légales

 

· © 2022 infYnity-biomarkers ·

Web Design MymensinghPremium WordPress ThemesWeb Development